Director Flow Cytometry-Research & Regenerative Medicine & Professor of Regenerative Medicine and Cellular Therapies
IASO Materbity & Research Hospital & EUC
Nea Ionia Athens, Attiki, Greece
Professor Dr. Vasiliki E. Kalodimou is the Director at the Flow Cytometry-Research and Regenerative Medicine Department of IASO Maternity-Pediatric and Research Hospital in Athens, Greece, as well as the Assistant Professor and the acting Chair, at the European University-Cyprus Ltd. Frankfurt Branch as well as the acting chair, collaborative Partner for the Greek Research Infrastructure for the visualization and monitoring of fundamental Processes in Biology and Medicine (BIOIMAGING-GR) at NCSR "DEMOKRITOS", Athens-Greece, the collaborative partner for training and research for Regenerative Medicine Program at the Institute of Personalized Molecular Medicine at the Medical City Hospital, Philippines, the Board/Committee on Research Ethics at the National Hellenic Research Foundation (Ε.Ι.Ε), she elected to serve as the Vice-Chair of the UEL Alumni Advisory Board, previously was the CBB Director & Processing Facility Director at MedStem-Cryobanks of IASO. Before her current appointment, Kalodimou served as a hematology research associate at General University Hospital of Heraklion, Crete, and as an instructor at both the General University Hospital of Heraklion and the Ipokratios Medical-Technical Institute of Athens.
Kalodimou received her bachelor’s degree in Human Physiology and her master’s degree in Human Molecular Genetics from the Imperial College University of Medicine in London, UK. She completed her PhD at the University of Medicine in Athens, Greece, with an emphasis on stem cells and factors affecting their viability and absolute numbers and her specialty in genetics and cancer at Harvard University USA.
Since 2006, Dr. Kalodimou has studied and working with stem cells from placenta, umbilical cord and adipose tissue, in every day practice and their applications in regenerative medicine, clinical trials, medical tourism and Flow Cytometry. Also is working in the area of human genetics & population genetics as well as cellular standards.
In collaboration with the Hellenic Flow Cytometry Society, Kalodimou has developed quality control schemes for stem cell marker enumeration. The goal of her work is to find helpful new applications for flow cytometry, evaluate risk factors for stem cell infusion, and improve the clarity and accessibility of measurements by flow cytometry. Her work quantifies and ranks all risks of flow cytometry enumeration to prevent and minimize the false-positive results from different cytometer uses. She is also working to establish combinations of monoclonal antibodies for mesenchymal and adipose tissue stem cell enumeration.
In addition to collaboration with state universities and pharmaceutical companies on research projects (22), Kalodimou frequently publishes (53 & 11 books) her findings. She has 2 patents.
Her book: Basic Principles in Flow Cytometry, was published in 2013 by AABB Press USA.
She is a TEDx Speaker & a Skill Mentor at EUvsVirus for 2020 Covid-19 Pandemic & in October 2020 she received the AABB President’s Award and she received the Clinical Reviewer of the Year 2021 by Select Science: Scientists' Choice Awards 2021 and voted to receive the UEL Alumni Advisory Board Change Maker Award 2021 and 2023.
She is in the editorial board and a reviewer in several scientific international journals as well as board member in scientific organizing committee’s for medical conferences worldwide & she had received a letter of thanks from Queen Elizabeth of England for her studies/scientific work at Imperial College University of Medicine in London.
AM24-MN-30-L - Solve It! Scenarios in Apheresis and Cellular Therapy
Monday, October 21, 2024
3:30 PM - 5:00 PM
Disclosure(s): No financial relationships to disclose